We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
139 hedge funds and large institutions have $530M invested in Amphastar Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 51 increasing their positions, 54 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.92% more ownership
Funds ownership: 57.23% → 58.15% (+0.92%)
3% less capital invested
Capital invested by funds: $549M → $530M (-$18.3M)
6% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 54
5% less funds holding
Funds holding: 146 → 139 (-7)
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
Holders
139
Holders Change
-7
Holders Change %
-4.79%
% of All Funds
2.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
51
Reduced
54
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$8.14M |
| 2 |
Millennium Management
New York
|
+$3.53M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$3.29M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.42M |
| 5 |
Morgan Stanley
New York
|
+$2.02M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$5.27M |
| 2 |
BlackRock
New York
|
-$1.8M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.59M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.45M |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
-$1.17M |
